GlassScriptPhysician profile
Carter L Capra
NPI 1033559430
$20,739.36
in general payments reported to CMS, 2019-2025
91 companies · $4,020 in 2025
The $4,020 reported for 2025 was more than what 79% of Hematology & Oncology providers received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,353 · 2020: $1,372 · 2021: $2,094 · 2022: $4,105 · 2023: $3,214 · 2024: $3,582 · 2025: $4,020.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $11K · Education: $128.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $10,688.45 |
| Education | $127.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $2,028.71 | 2019-2025 | |
| Alexion Pharmaceuticals, INC. | $1,900.18 | 2019-2024 | Soliris, Ultomiris |
| E.R. Squibb & Sons, L.L.C. | $1,115.24 | 2019-2025 | Opdivo, Opdualag, Krazati |
| Astrazeneca Pharmaceuticals LP | $988.08 | 2019-2025 | Imfinzi, Calquence, Enhertu |
| Celgene Corporation | $967.72 | 2019-2025 | Reblozyl, Pomalyst, Opdualag |
| Merck Sharp & Dohme LLC | $929.30 | 2019-2025 | Keytruda, Lynparza, Welireg |
| Janssen Biotech, INC. | $868.09 | 2019-2025 | Darzalex, Erleada, Rybrevant |
| Seagen INC. | $604.25 | 2019-2023 | Adcetris, Tukysa, Padcev |
| Abbvie INC. | $592.40 | 2021-2025 | Venclexta |
| Pfizer INC. | $520.62 | 2019-2025 | |
| Amgen INC. | $515.46 | 2019-2022 | |
| Daiichi Sankyo INC. | $506.25 | 2019-2025 | Enhertu, Datroway, Injectafer |
| Eisai INC. | $472.75 | 2019-2024 | |
| Incyte Corporation | $459.92 | 2019-2025 | Jakafi, Monjuvi, Pemazyre |
| Ipsen Biopharmaceuticals, INC | $447.78 | 2019-2025 | Onivyde, Somatuline Depot |
Show all 91 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $447.09 | 2023-2025 | Fruzaqla, Ninlaro, Iclusig |
| Genentech USA, INC. | $431.65 | 2019-2025 | Polivy, Lunsumio, Columvi |
| Genzyme Corporation | $398.21 | 2019-2025 | |
| Sobi, INC | $375.04 | 2022-2025 | |
| Lilly USA, LLC | $334.30 | 2019-2025 | Jaypirca, Verzenio, Retevmo |
| Stemline Therapeutics INC. | $278.23 | 2023-2025 | Orserdu |
| Pharmacyclics LLC, An Abbvie Company | $253.40 | 2019-2023 | Imbruvica, Epkinly |
| Deciphera Pharmaceuticals INC. | $240.34 | 2021-2025 | Qinlock, Romvimza, Tgct |
| Beigene USA, INC. | $239.08 | 2020-2025 | Brukinsa, Tevimbra |
| Myriad Genetic Laboratories, INC. | $223.79 | 2021-2023 | Precisetumor |
| Regeneron Healthcare Solutions, INC. | $195.90 | 2019-2025 | Libtayo |
| Glaxosmithkline, LLC. | $190.82 | 2019-2025 | Jemperli, Shingrix |
| Exelixis INC. | $190.41 | 2019-2025 | Cabometyx |
| Gilead Sciences, INC. | $180.43 | 2021-2025 | Trodelvy |
| Pharmaessentia USA Corporation | $176.56 | 2023-2025 | Besremi |
| Immunocore Limited | $167.81 | 2025 | Kimmtrak |
| Intera Oncology, INC | $166.92 | 2024 | Intera |
| Bayer Healthcare Pharmaceuticals INC. | $154.53 | 2019-2025 | |
| Pharmacosmos Therapeutics INC. | $150.47 | 2021-2025 | Monoferric |
| Karyopharm Therapeutics INC. | $145.78 | 2020-2025 | Xpovio |
| Beone Medicines USA, INC. | $144.34 | 2025 | Tevimbra, Brukinsa |
| Tesaro, INC. | $134.45 | 2019 | |
| Astellas Pharma US INC | $129.43 | 2019-2025 | Vyloy, Xtandi |
| Puma Biotechnology, INC. | $125.23 | 2019-2023 | Nerlynx |
| Kite Pharma, INC. | $102.10 | 2022-2025 | Yescarta |
| Springworks Therapeutics, INC. | $98.33 | 2024-2025 | Ogsiveo |
| Octapharma USA, INC. | $97.00 | 2020 | |
| Sumitomo Pharma America, INC. | $96.95 | 2023-2025 | Orgovyx |
| Iovance Biotherapeutics, INC. | $96.19 | 2024-2025 | Amtagvi |
| Aveo Pharmaceuticals, INC. | $95.63 | 2021-2025 | |
| Blueprint Medicines Corporation | $92.37 | 2023-2024 | Ayvakit |
| Genmab U.S., INC. | $87.43 | 2023-2025 | Epkinly |
| Servier Pharmaceuticals LLC | $84.59 | 2024-2025 | |
| Adc Therapeutics America, INC. | $79.04 | 2022-2025 | |
| Jazz Pharmaceuticals INC. | $77.24 | 2021-2025 | |
| Array Biopharma INC | $70.37 | 2022-2025 | Braftovi, Mektovi, Tukysa |
| Emd Serono, INC. | $68.61 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.56 | 2020-2025 | |
| Taiho Oncology, INC. | $64.94 | 2021-2025 | |
| Epizyme, INC. | $62.61 | 2020-2021 | |
| Csl Behring | $58.03 | 2019-2022 | |
| Eusa Pharma (US) LLC | $49.42 | 2019-2022 | |
| Pharming Healthcare, INC. | $49.18 | 2023-2025 | Ruconest |
| Aurobindo Pharma USA, INC. | $48.66 | 2019-2020 | |
| Recordati_rare_diseases_inc. | $44.89 | 2024-2025 | Sylvant |
| Acrotech Biopharma INC. | $41.76 | 2024 | Beleodaq |
| Shield Therapeutics INC | $39.54 | 2023-2024 | Accrufer |
| Rigel Pharmaceuticals, INC. | $37.37 | 2020-2023 | Rezlidhia, Tavalisse |
| Cti Biopharma Corp. | $36.93 | 2022-2023 | Vonjo |
| Novocure INC. | $35.06 | 2025 | Optune Lua (Novottf-200t) |
| Agios Pharmaceuticals, INC. | $34.41 | 2025 | Pyrukynd |
| Janssen Pharmaceuticals, INC | $33.91 | 2019-2021 | |
| Mirati Therapeutics, INC. | $33.41 | 2023 | Krazati |
| Dendreon Pharmaceuticals LLC | $32.95 | 2025 | Provenge |
| Fennec Pharmaceuticals, INC. | $32.67 | 2025 | Fyarro |
| Adaptive Biotechnologies Corporation | $29.86 | 2023-2024 | Clonoseq |
| Amag Pharmaceuticals, INC. | $29.76 | 2021 | |
| Bard Access Systems, INC. | $25.65 | 2019 | |
| Immunogen, INC. | $24.84 | 2023 | Elahere |
| Kyowa Kirin, INC. | $24.57 | 2019-2020 | |
| Tersera Therapeutics LLC | $24.08 | 2024 | Quzyttir |
| Mallinckrodt Enterprises LLC | $21.56 | 2019 | |
| Apellis Pharmaceuticals, INC. | $19.13 | 2023 | Empaveli |
| Sanofi-Aventis U.S. LLC | $19.06 | 2021 | |
| Morphosys, US INC. | $18.84 | 2023 | Monjuvi |
| Telix Pharmaceuticals | $17.60 | 2023 | Illuccix |
| Legend Biotech USA INC. | $16.61 | 2025 | Carvykti |
| Coherus Oncology, INC. | $16.41 | 2025 | Loqtorzi |
| Dova Pharmaceuticals | $16.26 | 2019 | |
| Becton, Dickinson and Company | $15.94 | 2019 | |
| Caris Mpi, INC. | $15.53 | 2025 | Mi Cancer Seek |
| Acceleron Pharma, INC. | $14.44 | 2021 | |
| Spectrum Pharmaceuticals INC. | $14.43 | 2025 | Rolvedon |
| Verastem, INC. | $13.44 | 2019 | |
| Secura Bio, INC. | $11.53 | 2020 | |
| Janssen Scientific Affairs, LLC | $10.71 | 2019 |
Drugs and devices associated with these payments
Keytruda $563Kisqali $443Enhertu $401Reblozyl $368Venclexta $324Lynparza $293Orserdu $278Somatuline Depot $262Onivyde $262Imbruvica $259Fruzaqla $256Imfinzi $240Scemblix $235Epkinly $226Pluvicto $213Sarclisa $197Opdivo $196Jaypirca $191Qinlock $187Adcetris $180Brukinsa $178Besremi $177Libtayo $173Kimmtrak $168Intera $167Jakafi $164Lenvima $161Verzenio $153Orgovyx $153Ninlaro $144Lutathera $142Tukysa $141Vonjo $141Elahere $140Polivy $127Monjuvi $124Gamifant $115Tevimbra $109Lunsumio $107Columvi $107Calquence $102Ogsiveo $98.33Amtagvi $96.19Tasigna $94.21Ayvakit $92.37Cabometyx $87.88Fabhalta $87.42Darzalex $81.36Tecentriq $80.34Monoferric $80.12Pemazyre $79.53Stivarga $77.45Precisetumor $76.63Welireg $70.61Retevmo $70.44Doptelet $69.37Trodelvy $68.26Tivdak $67.83Pomalyst $67.81Ibrance $67.59Jemperli $66.33Piqray $66.25Promacta $65.67Zepzelca $64.31Opdualag $60.31Elrexfio $60.05Nubeqa $59.94Romvimza $57.67Padcev $57.60Soliris $56.31Xpovio $54.07Xtandi $52.39Lonsurf $51.62Inqovi $51.62Mekinist $51.47Ruconest $49.18Yescarta $48.59Krazati $46.63Ultomiris $45.60Sylvant $44.89Vitrakvi $44.39Fotivda $43.31Datroway $42.17Beleodaq $41.76Zynlonta $39.90Erleada $39.57Accrufer $39.54Illuccix $35.20Optune Lua (Novottf-200t) $35.06Rybrevant $34.64Pyrukynd $34.41Tecvayli $33.66Provenge $32.95Tibsovo $32.71Fyarro $32.67Tgct $31.86Clonoseq $29.86Itovebi $28.76Cablivi $27.55Enjaymo $27.55
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carter Capra listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.